Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the long-term maintenance of efficacy of Lu AA21004 in patients with
Generalized Anxiety Disorder (GAD) who responded to acute treatment with Lu AA21004.